Mutations affecting dosage compensation in Drosophila melanogaster: effects in the germline.
Dosage compensation is the process by which the total amount of gene products of X-linked genes is equalized in females (2X;2A) and males (X;2A). The achievement of dosage compensation takes place at the transcriptional level. Mutations have been isolated that impair the dosage compensation process. These mutations are the male-specific lethals msl-1, msl-2, and mle, which have been analyzed in the somatic tissues. Our aim was to know whether these mutations affect the germline. For this purpose, pole cells homozygous for the male-specific lethal mutations were transplanted into wild-type host embryos, and we checked whether the mutant pole cells were capable of forming functional sperm. The results are as follows: the msl-1 and msl-2 genes are not needed in the germline, while the mle gene seems to be required for normal spermatogenesis.[1]References
- Mutations affecting dosage compensation in Drosophila melanogaster: effects in the germline. Bachiller, D., Sánchez, L. Dev. Biol. (1986) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
